Evaluation of eCPR Survivors

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05339854
Collaborator
(none)
30
1
8
3.8

Study Details

Study Description

Brief Summary

A cardiac arrest event has severe impact on the patient´s health-related quality of life. Survival of cardiac arrest does not innately translate to favorable quality of life. In particular, highly invasive resuscitation strategies, including extracorporeal cardio-pulmonary resuscitation (ECPR) due to therapy-refractory cardiac arrest, may have impact on long-term outcomes. Therefore, apart from acute medical treatment and physical rehabilitation, long-term effects on cardio-pulmonary, physical and neuro-psychiatric functions after cardiac arrest survival have to be evaluated and optimized. We plan to investigate a bundle of cardio-pulmonary, physical and neuro-psychiatric functions in patients who survived a therapy-refratory cardiac arrest with ECPR.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of Cardio-pulmonary, Physcial and Neuro-psychiatric Function in Patients Who Survived a Therapy-refractory Cardiac Arrest With Extracorporeal Cardiopulmonary Resuscitation.
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Dec 30, 2022
Anticipated Study Completion Date :
Jan 30, 2023

Arms and Interventions

Arm Intervention/Treatment
ECPR survivor

Adult patient who survived therapy-refractory cardiac arrest with extracorporeal cardiopulmonary resuscitation (ECPR).

Device: VA-ECMO or ECMELLA
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO); ECMELLA: VA-ECMO and left-ventricular Impella micro-axial pump

Outcome Measures

Primary Outcome Measures

  1. Left ventricular ejection fraction (LVEF) [LVEF witihin one year after index cardiac arrest event.]

    LVEF measured with transthoracic echocardiography.

Secondary Outcome Measures

  1. Cognitive function [Cognitive function witihin one year after index cardiac arrest event.]

    Cognitive function measured with a standardized questionnaire and following established scores: Mini-mental-status-test [0-30 points; higher score means better outcome], Cerebral Performance Categories Scale [1-5; lower score means better outcome].

  2. Sign and symptoms of heart failure [Sign and symptoms of heart failure witihin one year after index cardiac arrest event.]

    Sign and symptoms of heart failure measured with a standardized questionnaire and following established score: European Quality of Life 5 Dimensions 3 Level Version [0-100 points; higher score means better outcome].

  3. Activity of daily living (ADL) [ADL witihin one year after index cardiac arrest event.]

    ADL measured with a standardized questionnaire and following estbalished score: Barthel index [0-100 points; higher score means better outcome].

  4. Comorbidity level [Comorbidity level witihin one year after index cardiac arrest event.]

    Comorbidity level measured with following established score: Charlson comorbidity index [0-24 points; lower score means better outcome].

  5. Number of cardiovascular medications [Number of cardiovascular medication witihin one year after index cardiac arrest event.]

    Number of cardiovascular medications documented with a standardized questionnaire.

  6. Cardiac stress test: Ergometry [Physical function witihin one year after index cardiac arrest event.]

    Quantitative test to evaluate cardiopulmonary exercise tolerance and physical capacity by using a bicycle.

  7. Cardiac stress test: Walking distance [Physical function witihin one year after index cardiac arrest event.]

    Quantitative test to evaluate endurance and aerobic capacity by walking for six minutes (six minute walk test).

  8. Vital function: Blood pressure [Blood pressure witihin one year after index cardiac arrest event.]

    Non-invasive blood pressure measurement at rest (unit: mmHg).

  9. Vital function: Electrocardiogram (ECG) [ECG activity witihin one year after index cardiac arrest event.]

    12-lead ECG measurement at rest.

  10. Vital function: Peripheral oxygen saturation [Peripheral oxygen saturation witihin one year after index cardiac arrest event.]

    Peripheral oxygen saturation measurement at rest by using pulsoximetry (unit: percent).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients

  • Survival of cardiac arrest

  • Use of extracorporeal cardiopulmonary resuscitation (ECPR) with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or ECMELLA (VA-ECMO and left-ventricular Impella micro-axial pump)

Exclusion Criteria:
  • Non-adult patients

  • No cardiac arrest

  • No use of ECPR

  • Inability to comply with follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 Charité - Universitätsmedizin Berlin Berlin Germany 12203

Sponsors and Collaborators

  • Charite University, Berlin, Germany

Investigators

  • Study Director: Carsten Skurk, MD, Charite Univesity
  • Principal Investigator: Tharusan Thevathasan, MD, Charite Univesity

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tharusan Thevathasan, Principal Investigator, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT05339854
Other Study ID Numbers:
  • ECPR Outpatient Clinic
First Posted:
Apr 21, 2022
Last Update Posted:
Apr 21, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2022